← FDA Drug Approvals (Drugs@FDA)

SOJOURN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PIRAMAL CRITICAL · Approved 2007-05-02

Drug application

FDA Application #
ANDA077867
Application type
Abbreviated New Drug Application (Generic)
Brand name
SOJOURN
Generic name
SEVOFLURANE
Active ingredients
SEVOFLURANE
Dosage form
LIQUID
Route
INHALATION
Marketing status
Prescription
Sponsor
PIRAMAL CRITICAL
Manufacturer
Piramal Critical Care Inc
First approval
2007-05-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown